Literature DB >> 20392836

Increased expression of angiogenic genes in the brains of mouse meg3-null embryos.

Francesca E Gordon1, Catherine L Nutt, Pornsuk Cheunsuchon, Yuki Nakayama, Katelyn A Provencher, Kimberley A Rice, Yunli Zhou, Xun Zhang, Anne Klibanski.   

Abstract

Maternally expressed gene 3 (MEG3) is a noncoding RNA highly expressed in the normal human brain and pituitary. Expression of MEG3 is lost in gonadotroph-derived clinically nonfunctioning pituitary adenomas. Meg3 knockout mice were generated to identify targets and potential functions of this gene in embryonic development and tumorigenesis. Gene expression profiles were compared in the brains of Meg3-null embryos and wild-type littermate controls using microarray analysis. Microarray data were analyzed with GeneSifter, which uses Kyoto Encyclopedia of Genes and Genomes pathways and Gene Ontology classifications to identify signaling cascades and functional categories of interest within the dataset. Differences were found in signaling pathways and ontologies related to angiogenesis between wild-type and knockout embryos. Quantitative RT-PCR and immunohistological staining showed increased expression of some Vascular Endothelial Growth Factor pathway genes and increased cortical microvessel density in the Meg3-null embryos. In conclusion, Meg3 may play an important role in control of vascularization in the brain and may function as a tumor suppressor in part by inhibiting angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20392836      PMCID: PMC2875815          DOI: 10.1210/en.2009-1151

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  56 in total

1.  KEGG: kyoto encyclopedia of genes and genomes.

Authors:  M Kanehisa; S Goto
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

2.  Gene ontology: tool for the unification of biology. The Gene Ontology Consortium.

Authors:  M Ashburner; C A Ball; J A Blake; D Botstein; H Butler; J M Cherry; A P Davis; K Dolinski; S S Dwight; J T Eppig; M A Harris; D P Hill; L Issel-Tarver; A Kasarskis; S Lewis; J C Matese; J E Richardson; M Ringwald; G M Rubin; G Sherlock
Journal:  Nat Genet       Date:  2000-05       Impact factor: 38.330

3.  Vascular endothelial growth factor (VEGF)-driven actin-based motility is mediated by VEGFR2 and requires concerted activation of stress-activated protein kinase 2 (SAPK2/p38) and geldanamycin-sensitive phosphorylation of focal adhesion kinase.

Authors:  S Rousseau; F Houle; H Kotanides; L Witte; J Waltenberger; J Landry; J Huot
Journal:  J Biol Chem       Date:  2000-04-07       Impact factor: 5.157

4.  Up-regulation of the Notch ligand Delta-like 4 inhibits VEGF-induced endothelial cell function.

Authors:  Cassin Kimmel Williams; Ji-Liang Li; Matilde Murga; Adrian L Harris; Giovanna Tosato
Journal:  Blood       Date:  2005-10-11       Impact factor: 22.113

5.  A repressor sequence in the juxtamembrane domain of Flt-1 (VEGFR-1) constitutively inhibits vascular endothelial growth factor-dependent phosphatidylinositol 3'-kinase activation and endothelial cell migration.

Authors:  H Gille; J Kowalski; L Yu; H Chen; M T Pisabarro; T Davis-Smyth; N Ferrara
Journal:  EMBO J       Date:  2000-08-01       Impact factor: 11.598

6.  Antiangiogenic activity of the MDM2 antagonist nutlin-3.

Authors:  Paola Secchiero; Federica Corallini; Arianna Gonelli; Raffaella Dell'Eva; Marco Vitale; Silvano Capitani; Adriana Albini; Giorgio Zauli
Journal:  Circ Res       Date:  2006-11-30       Impact factor: 17.367

7.  Identification of an imprinted gene, Meg3/Gtl2 and its human homologue MEG3, first mapped on mouse distal chromosome 12 and human chromosome 14q.

Authors:  N Miyoshi; H Wagatsuma; S Wakana; T Shiroishi; M Nomura; K Aisaka; T Kohda; M A Surani; T Kaneko-Ishino; F Ishino
Journal:  Genes Cells       Date:  2000-03       Impact factor: 1.891

8.  Immunohistochemical analysis of tumor angiogenic factors in human pituitary adenomas.

Authors:  María Niveiro; F Ignacio Aranda; Gloria Peiró; Cristina Alenda; Antonio Picó
Journal:  Hum Pathol       Date:  2005-10       Impact factor: 3.466

9.  The mouse Gtl2 gene is differentially expressed during embryonic development, encodes multiple alternatively spliced transcripts, and may act as an RNA.

Authors:  K Schuster-Gossler; P Bilinski; T Sado; A Ferguson-Smith; A Gossler
Journal:  Dev Dyn       Date:  1998-06       Impact factor: 3.780

10.  Epigenetic alteration at the DLK1-GTL2 imprinted domain in human neoplasia: analysis of neuroblastoma, phaeochromocytoma and Wilms' tumour.

Authors:  D Astuti; F Latif; K Wagner; D Gentle; W N Cooper; D Catchpoole; R Grundy; A C Ferguson-Smith; E R Maher
Journal:  Br J Cancer       Date:  2005-04-25       Impact factor: 7.640

View more
  74 in total

Review 1.  Transcribed dark matter: meaning or myth?

Authors:  Chris P Ponting; T Grant Belgard
Journal:  Hum Mol Genet       Date:  2010-08-25       Impact factor: 6.150

Review 2.  Regulation of mammary epithelial cell homeostasis by lncRNAs.

Authors:  Amy N Shore; Jeffrey M Rosen
Journal:  Int J Biochem Cell Biol       Date:  2014-03-26       Impact factor: 5.085

Review 3.  Non-coding RNAs as regulators of gene expression and epigenetics.

Authors:  Minna U Kaikkonen; Michael T Y Lam; Christopher K Glass
Journal:  Cardiovasc Res       Date:  2011-05-09       Impact factor: 10.787

Review 4.  Molecular function and regulation of long non-coding RNAs: paradigms with potential roles in cancer.

Authors:  Mohammadreza Hajjari; Atefeh Khoshnevisan; Young Kee Shin
Journal:  Tumour Biol       Date:  2014-09-30

Review 5.  Cardinal Epigenetic Role of non-coding Regulatory RNAs in Circadian Rhythm.

Authors:  Utpal Bhadra; Pradipta Patra; Manika Pal-Bhadra
Journal:  Mol Neurobiol       Date:  2017-05-17       Impact factor: 5.590

Review 6.  Regulation of mammalian cell differentiation by long non-coding RNAs.

Authors:  Wenqian Hu; Juan R Alvarez-Dominguez; Harvey F Lodish
Journal:  EMBO Rep       Date:  2012-10-16       Impact factor: 8.807

Review 7.  Could lncRNAs be the missing links in control of mesenchymal stem cell differentiation?

Authors:  Coralee E Tye; Jonathan A R Gordon; Lori A Martin-Buley; Janet L Stein; Jane B Lian; Gary S Stein
Journal:  J Cell Physiol       Date:  2015-03       Impact factor: 6.384

Review 8.  The role of long non-coding RNAs in neurodevelopment, brain function and neurological disease.

Authors:  Thomas C Roberts; Kevin V Morris; Matthew J A Wood
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2014-09-26       Impact factor: 6.237

Review 9.  Long non-coding RNAs in stem cells and cancer.

Authors:  Gabriel Eades; Yong-Shu Zhang; Qing-Lin Li; Ji-Xiang Xia; Yuan Yao; Qun Zhou
Journal:  World J Clin Oncol       Date:  2014-05-10

Review 10.  Long noncoding RNAs: a new regulatory code in osteoarthritis.

Authors:  Xiao Cen; Xin-Qi Huang; Wen-Tian Sun; Qing Liu; Jun Liu
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.